---
schema_version: "secwatch.filing_event.v1"
accession: "0000883984-26-000028"
form_type: "8-K"
ticker: "ICUI"
cik: "0000883984"
company_name: "ICU MEDICAL INC/DE"
filed_at: "2026-05-07T23:59:59+00:00"
generated_at: "2026-05-14T22:21:35.305825+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# ICU Medical Q1 GAAP net income $30.1M vs loss a year ago; organic revenue up 1%

## Summary
- GAAP revenue $530.2M, down 12% YoY due to IV Solutions divestiture; non-GAAP organic revenue up 1%.
- GAAP gross margin improved to 39% from 35%; gross profit $206.2M vs $210.1M.
- GAAP diluted EPS $1.20 vs $(0.63) loss; adjusted diluted EPS $1.97 vs $1.72.
- Adjusted EBITDA $98.7M vs $99.4M; company reiterates focus on innovation and operational efficiency.
- Results reflect first full quarter without IV Solutions; management highlights margin expansion and cash flow.

## SEC filing metadata
- accession: 0000883984-26-000028
- form_type: 8-K
- ticker: ICUI
- cik: 0000883984
- company_name: ICU MEDICAL INC/DE
- filed_at: 2026-05-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/883984/000088398426000028/0000883984-26-000028-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/883984/000088398426000028/icui-20260507.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000883984-26-000028
- JSON: https://secwatch.observer/filing/0000883984-26-000028.json
- Plain text: https://secwatch.observer/filing/0000883984-26-000028.txt

## Source-grounded claims
- claim_id: 456d4334ece7bf4efc19d62c813ad35f184f11a4
  claim: ICU MEDICAL INC/DE reported first quarter of 2026 results: revenue $530.2 million, net income $30.1 million, EPS $1.20 per diluted share.
  evidence_excerpt: First quarter 2026 GAAP revenue was $530.2 million, as compared to $604.7 million in the same period in the prior year. GAAP gross profit for the first quarter of 2026 was $206.2 million, as compared to $210.1 million in the same period in the prior year. GAAP gross margin for the first quarter of 2026 was 39%, as compared to 35% in the same period in the prior year. GAAP net income for the first quarter of 2026 was $30.1 million, or $1.20 per diluted share
  evidence_url: https://www.sec.gov/Archives/edgar/data/883984/000088398426000028/0000883984-26-000028-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.